ISPOR ANNOUNCES NEW 2017 HEALTH ECONOMICS AND OUTCOMES RESEARCH TRAINING PROGRAMS

Published Dec 5, 2016
Princeton, NJ—December 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced  its upcoming health economics and outcomes research (HEOR) in-person training programs scheduled for early 2017.   ISPOR Health Technology Assessment (HTA) Training Program 20-23 February 2017 | Bogotá, Colombia The ISPOR Health Technology Assessment (HTA) Training Program is designed “HTA users and doers” in government in addition to public and private payers, industry, health plans, academia, and patient group representatives interested in learning how to conduct various aspects of HTA with an emphasis on clinical and economic evaluation. Program faculty includes Finn Børlum Kristensen, MD, PhD, Manuel Espinoza, MD, MSc, PhD, and Aurelio Mejía, MSc, BSc. Additional information on the training can be found here. Essential Elements of Pricing Training Program March 9-10, 2017 | Philadelphia, PA, USA The Essential Elements of Pricing Training Program educates attendees on the context, rules, and processes behind pharmaceutical pricing in addition to an overview of the tradeoffs, commonalities, and differences between markets and disease areas. Faculty for the program includes, Jack Mycka and Renato Dellamano. Additional information can be found here. Introduction to Health Economics and Outcomes Research Training Program April 6-7, 2017 | San Francisco, CA, USA The Introduction to Health Economics and Outcomes Research (HEOR): Principles and Practice in Health Care Decision Making Training Program. Provides participants with the essential skills required to perform and critique health care economic studies and models to determine cost-effective medications, devices, and interventions. This training will be led by Lorne E. Basskin, PharmD. Program information can be found here. Additional information on ISPOR In-Person Training Programs can be found here and details on the ISPOR HTA Training Program can be found here.

###

 

Related Stories

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.

ISPOR Launches “HEOR Explained” Microsite

Dec 10, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has launched a new microsite—HEOR Explained—designed to help people better understand how health economics and outcomes research (HEOR) can improve healthcare decisions.

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×